<?xml version="1.0" encoding="UTF-8"?>
<p>Data obtained from the experiments involving treatment of SARS-CoV and MERS-CoV and ISGâ€™s ability to disrupt the IFN signaling pathway would be valuable for selecting IFN-beta as a potential treatment option against SARS-CoV-2 [
 <xref rid="R44" ref-type="bibr">44</xref>, 
 <xref rid="R45" ref-type="bibr">45</xref>].
</p>
